An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to users administering products of unknown origin.
Some professionals said the demand for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking penalties, legal action or imprisonment.
Service Reaction and Content Elimination
According to TikTok, the service has removed problematic content and prohibited related hashtags and query recommendations. The company said it was committed to keeping the service safe and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Research also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.
After moments of entering one community, a seller posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or previous experience.
Item Information and Pricing
Within these communities, posts show dark colored packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A representative for Telegram said it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has already seen patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational product not yet approved … may subject users to potentially serious health risks”.
